HCAT

Health Catalyst's stock price has experienced significant volatility over the past six months. Key events impacting the stock include the Q3 2025 earnings report, which exceeded guidance, and the Q4 and year-end 2025 operating results, which led to a stock plunge due to missed earnings estimates and a lack of annual guidance. Analyst downgrades and price target cuts also occurred in March 2026. The Q1 2026 earnings report is scheduled for May 11, 2026, with analysts expecting a year-on-year revenue decline.